Gavi-supported immunisation generated more than US$ 30 billion in economic benefits in 2025, through lower healthcare costs and healthier, more productive populations Recognising the value of immunisation, countries invested a record US$ 301 million in co-financing of Gavi-supported vaccines in 2025 Dr Sania Nishtar, Gavi CEO: “When it comes to immunisation we know that the…
Young people in low- and middle-income countries appear generally more optimistic about how AI can enhance their work prospects and social lives than their western peers, according to our new survey of people in ten countries in Africa and South Asia. While debates in higher-income countries often focus on job losses, misinformation and mental health…
Major push by Gavi, the Vaccine Alliance and lower-income countries to extend access to the HPV vaccine has reached its target ahead of schedule – helping protect an estimated [1] 86 million girls in the world’s highest-risk countries from cervical cancer, and preventing an estimated 1.4 million future deaths By the end of 2025, the…
Geneva — Each year WHO and UNICEF release global and national routine immunisation coverage estimates (WUENIC).Gavi, the Vaccine Alliance analyses what the 2024 WUENIC data says about the state of immunisation in the 57 low- and lower-middle income countries it supports. KEY TAKEAWAYS Lower-income countries are protecting more people, against more diseases than ever before…
